"Cardiovascular risks of cyclooxygenase-2 inhibitors and traditional anti-inflammatory drugs: necessary but not sufficient for clinical decision making." by Charles H Hennekens

Selected Works of Steven Borzak, MD, FACC

Article

Cardiovascular risks of cyclooxygenase-2 inhibitors and traditional anti-inflammatory drugs: necessary but not sufficient for clinical decision making.

Expert Review of Cardiovascular Therapy (2014)

Charles H Hennekens, Florida Atlantic University
Steven Borzak, Florida Atlantic University
David J Bjorkman, Florida Atlantic University

Link

Disciplines

Medicine and Health Sciences,
Physical Therapy and
Critical Care

Publication Date

February 27, 2014

DOI

10.1586/14779072.2014.873700

Citation Information

Charles H Hennekens, Steven Borzak and David J Bjorkman. "Cardiovascular risks of cyclooxygenase-2 inhibitors and traditional anti-inflammatory drugs: necessary but not sufficient for clinical decision making." Expert Review of Cardiovascular Therapy Vol. 12 Iss. 3 (2014) p. 291 - 293
Available at: http://works.bepress.com/steven-borzak/28/